Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Published byAchim Weiß Modified over 5 years ago

Similar presentations

Presentation on theme: "Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi."— Presentation transcript:

1 Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer 
Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi Yoshida, MD, Shinichiro Motohashi, MD, Kazuhiro Yasufuku, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Kenzo Hiroshima, MD, Yukio Nakatani, MD, Takehiko Fujisawa, MD  The Annals of Thoracic Surgery  Volume 82, Issue 1, Pages (July 2006) DOI: /j.athoracsur Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Overall survival curves for patients (n = 75) with pulmonary metastasis from colorectal cancer. (A) Overall 5- and 10-year survival rates were 41.3% and 35.2%, respectively, after resection of pulmonary metastases. (B) Overall 5- and 10-year survival rates were 73.1% and 40.3%, respectively, after initial colorectal resection. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Survival curves according to serum carcinoembryonic antigen (CEA) concentration. (A) The 5- and 10-year survival rates after pulmonary resection were 11.2% and no survivors, respectively, for patients with elevated CEA (thin line); rates were 65.0% and 59.6%, respectively, for patients without elevation (thick line). (B) The 5- and 10-year survival rates after primary resection were 61.1% and 14.9%, respectively, for patients with elevated CEA (thin line); rates were 81.5% and 65.0%, respectively, for patients without elevation (thick line). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Survival curves according to site of primary tumor. (A) The 5- and 10-year survival rates after pulmonary resection were 52.2% and 47.4%, respectively, for patients with primary tumor in the colon (thin line); rates were 29.5% and no survivors, respectively, for patients with primary tumor in the rectum (thick line). (B) The 5- and 10-year survival rates after primary resection were 84.4% and 54.5%, respectively, for patients with primary colon tumors (thin line); rates were 61.2% and 23.6%, respectively, for patients with primary tumors in the rectum (thick line). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Survival curves according to prior hepatectomy for hepatic metastasis. (A) The 5- and 10-year survival rates after pulmonary resection were 31.6% and 31.6%, respectively, for patients who underwent resection of hepatic metastases (thick line); rates were 44.0% and 36.7%, respectively, for patients who did not undergo such surgery (thin line). (B) The 5- and 10-year survival rates after pulmonary resection were 66.6% and 31.7%, respectively, for patients who underwent resection of hepatic metastases (thick line); rates were 75.4% and 43.3%, respectively, for patients who did not undergo such surgery (thin line). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi."

Similar presentations

Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,

Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C

Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C
Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease  Yasuo Sekine, MD, Takekazu.

Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease  Yasuo Sekine, MD, Takekazu.
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.

Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study  Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng,

Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study  Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng,
A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer  Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD,

A Prospective Study of Surgical Procedures for Patients With Oligometastatic Non-Small Cell Lung Cancer  Chiaki Endo, MD, PhD, Tohru Hasumi, MD, PhD,
Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,
Ki-67 expression and prognosis for smokers with resected stage i Non–Small cell lung cancer  Yukiko Haga, MD, Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi.

Ki-67 expression and prognosis for smokers with resected stage i Non–Small cell lung cancer  Yukiko Haga, MD, Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi.
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Similar presentations

Ads by Google